Sonia Poli has worked within Swiss Stock Exchange listed companies Hoffman la Roche and Addex Therapeutics where she held leadership and executive positions across various disciplines in drug discovery, pre-clinical development and translational science and has interacted with regulatory authorities, investors and public funding institutions. Ms Poli also held various corporate responsibilities such as outsourcing and out-licensing and has promoted academic collaborations and supported R&D collaborations with external partners. She is an accomplished R&D professional with 20 years' international experience in large and small pharmaceutical companies. Ms Poli has broad knowledge of small molecule drug design, optimisation and early clinical development, with expertise which encompasses multiple therapeutic areas. She is co-author of more than 40 scientific papers and several patents. She holds a Masters degree and a PhD in industrial chemistry from Milan University (IT).
